226 related articles for article (PubMed ID: 21651352)
1. Animal models in the study of hepatitis C virus-associated liver pathologies.
Lerat H; Higgs M; Pawlotsky JM
Expert Rev Gastroenterol Hepatol; 2011 Jun; 5(3):341-52. PubMed ID: 21651352
[TBL] [Abstract][Full Text] [Related]
2. Hepatic steatosis and hepatitis C: Still unhappy bedfellows?
Hwang SJ; Lee SD
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():96-101. PubMed ID: 21199519
[TBL] [Abstract][Full Text] [Related]
3. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.
Salomao M; Yu WM; Brown RS; Emond JC; Lefkowitch JH
Am J Surg Pathol; 2010 Nov; 34(11):1630-6. PubMed ID: 20975341
[TBL] [Abstract][Full Text] [Related]
4. Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C.
García-Monzón C; Lo Iacono O; Mayoral R; González-Rodríguez A; Miquilena-Colina ME; Lozano-Rodríguez T; García-Pozo L; Vargas-Castrillón J; Casado M; Boscá L; Valverde AM; Martín-Sanz P
J Hepatol; 2011 Jan; 54(1):142-52. PubMed ID: 20888662
[TBL] [Abstract][Full Text] [Related]
5. Interaction of the hepatitis C virus (HCV) core with cellular genes in the development of HCV-induced steatosis.
Khan M; Jahan S; Khaliq S; Ijaz B; Ahmad W; Samreen B; Hassan S
Arch Virol; 2010 Nov; 155(11):1735-53. PubMed ID: 20842391
[TBL] [Abstract][Full Text] [Related]
6. Impact of HCV genetic differences on pathobiology of disease.
Ripoli M; Pazienza V
Expert Rev Anti Infect Ther; 2011 Sep; 9(9):747-59. PubMed ID: 21905784
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma.
El-Bassiouni A; Nosseir M; Zoheiry M; El-Ahwany E; Ghali A; El-Bassiouni N
APMIS; 2006 Jun; 114(6):420-7. PubMed ID: 16856963
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus, diabetes and steatosis: clinical evidence in favor of a linkage and role of genotypes.
Mihm S
Dig Dis; 2010; 28(1):280-4. PubMed ID: 20460924
[TBL] [Abstract][Full Text] [Related]
9. 8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
Chuma M; Hige S; Nakanishi M; Ogawa K; Natsuizaka M; Yamamoto Y; Asaka M
J Gastroenterol Hepatol; 2008 Sep; 23(9):1431-6. PubMed ID: 18854000
[TBL] [Abstract][Full Text] [Related]
10. Impact of amino acid substitutions in the hepatitis C virus genotype 1b core region on liver steatosis and hepatic oxidative stress in patients with chronic hepatitis C.
Tachi Y; Katano Y; Honda T; Hayashi K; Ishigami M; Itoh A; Hirooka Y; Nakano I; Samejima Y; Goto H
Liver Int; 2010 Apr; 30(4):554-9. PubMed ID: 19951380
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus and glucose and lipid metabolism.
Alaei M; Negro F
Diabetes Metab; 2008 Dec; 34(6 Pt 2):692-700. PubMed ID: 19195632
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of hepatocarcinogenesis in chronic hepatitis C virus infection.
Yamashita T; Honda M; Kaneko S
J Gastroenterol Hepatol; 2011 Jun; 26(6):960-4. PubMed ID: 21443660
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus diversity and hepatic steatosis.
Roingeard P
J Viral Hepat; 2013 Feb; 20(2):77-84. PubMed ID: 23301542
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
Petit JM; Benichou M; Duvillard L; Jooste V; Bour JB; Minello A; Verges B; Brun JM; Gambert P; Hillon P
Am J Gastroenterol; 2003 May; 98(5):1150-4. PubMed ID: 12809841
[TBL] [Abstract][Full Text] [Related]
15. Promotion of hepatocellular carcinoma by hepatitis C virus.
Bühler S; Bartenschlager R
Dig Dis; 2012; 30(5):445-52. PubMed ID: 23108300
[TBL] [Abstract][Full Text] [Related]
16. Lipid metabolism and liver disease in hepatitis C viral infection.
Koike K; Tsutsumi T; Yotsuyanagi H; Moriya K
Oncology; 2010 Jul; 78 Suppl 1():24-30. PubMed ID: 20616580
[TBL] [Abstract][Full Text] [Related]
17. Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C.
Sebastiani G; Vario A; Ferrari A; Pistis R; Noventa F; Alberti A
J Viral Hepat; 2006 Mar; 13(3):199-205. PubMed ID: 16475996
[TBL] [Abstract][Full Text] [Related]
18. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.
Moucari R; Asselah T; Cazals-Hatem D; Voitot H; Boyer N; Ripault MP; Sobesky R; Martinot-Peignoux M; Maylin S; Nicolas-Chanoine MH; Paradis V; Vidaud M; Valla D; Bedossa P; Marcellin P
Gastroenterology; 2008 Feb; 134(2):416-23. PubMed ID: 18164296
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen.
Lonardo A; Adinolfi LE; Restivo L; Ballestri S; Romagnoli D; Baldelli E; Nascimbeni F; Loria P
World J Gastroenterol; 2014 Jun; 20(23):7089-103. PubMed ID: 24966582
[TBL] [Abstract][Full Text] [Related]
20. Different mechanisms of steatosis in hepatitis C virus genotypes 1 and 3 infections.
Hézode C; Roudot-Thoraval F; Zafrani ES; Dhumeaux D; Pawlotsky JM
J Viral Hepat; 2004 Sep; 11(5):455-8. PubMed ID: 15357652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
